Impact of different therapeutic regimens on the outcome of patients with Cronh's disease of the upper gastrointestinal tract

Inflammatory Bowel Diseases

Volumn 7, Issue 2, 2001, Pages 99-105

  Miehsler, Wolfgang ^a,b   Püspök, Andreas ^a   Oberhuber, Georg ^a   Vogelsang, Harald ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

Azathioprine; Crohn's disease; Gastroduodenum; Mesalamine; Permeability; Prednisolone; Proton pump inhibitor; Therapy

Indexed keywords

AZATHIOPRINE; C REACTIVE PROTEIN; FAMOTIDINE; HISTAMINE H2 RECEPTOR ANTAGONIST; LANSOPRAZOLE; MESALAZINE; OMEPRAZOLE; PREDNISOLONE; PROTON PUMP INHIBITOR; STOMACH SECRETION INHIBITOR;

ADULT; ARTICLE; BIOCHEMISTRY; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CROHN DISEASE; DIGESTIVE TRACT PARAMETERS; FEMALE; FOLLOW UP; GASTROINTESTINAL ENDOSCOPY; GASTROINTESTINAL SURGERY; HISTOPATHOLOGY; HUMAN; INTESTINE MUCOSA PERMEABILITY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SYMPTOMATOLOGY; TREATMENT OUTCOME; UPPER GASTROINTESTINAL TRACT;

EID: 0034782710     PISSN: 10780998     EISSN: None     Source Type: Journal    
DOI: 10.1097/00054725-200105000-00004     Document Type: Article

References (41)

1. Crohn's disease of the duodenum
2. Crohn's disease of the stomach and duodenum: A clinical study with emphasis on the value of endoscopy and endoscopic biopsies
3. Crohn's disease of the upper gastrointestinal tract
4. Clinical features of Crohn's disease in adolescents
5. Endoscopic features of gastroduodenal Crohn's disease
6. Crohn's disease in endoscopic biopsies of the gastric antrum and duodenum
7. Duodenal Crohn's disease: An analysis of 89 cases
8. Morphologie granulomatoeser Schleimhautveraenderungen des oberen Gastrointestinaltractes bei Morbus Crohn
9. Focally enhanced gastritis: A frequent type of gastritis in patients with Crohn's disease
10. High incidence of upper gastrointestinal tract involvement in Crohn's disease
11. Upper and lower gastrointestinal endoscopy in children and adolescents with Crohn's disease: A prospective study
12. High frequency of helicobacter negative gastritis in patients with Crohn's disease
13. Endoscopic and bioptic study of the upper gastrointestinal tract in Crohn's disease patients
14. Gastroduodenal permeability in Crohn's disease
15. Increased gastric and intestinal permeability in patients with Crohn's disease
16. Intestinal permeability and the prediction of relapse in Crohn's disease
17. Sucrose: A novel permeability marker for gastroduodenal disease
18. Lymphocytic gastritis in patients with celiac disease
19. A simple non-invasive marker of gastric damage: Sucrose permeability
20. Development of Crohn's disease activity index
21. Differential diagnosis of inflammatory bowel disease. A comparison of various diagnostic classifications
22. The differential diagnosis of Crohn's disease and ulcerative colitis
23. Endoscopic and bioptic findings in the upper gastrointestinal tract in patients with Crohn's disease
24. Crohn's disease of the upper gastrointestinal tract
25. The diagnosis of gastroduodenal Crohn's disease by endoscopic biopsy
26. Focal gastric inflammatory infiltrates in inflammatory bowel disease: Prevalence, immunohistochemical characteristics and diagnostic role
27. Symptomatic improvement of gastroduodenal Crohn's disease with omeprazole
28. Omeprazole for duodenal ulceration in Crohn's disease
29. Esophageal Crohn's disease: Treat the inflammation, not just the symptom
30. Omeprazole in possible esophageal Crohn's disease
31. Gastroduodenal Crohn's disease: Diagnosis and selection of treatment
32. Release of 5-ASA from Pentasa in patients with Crohn's disease of the small intestine
33. Delivery and fate of oral mesalamine microgranules within the human small intestine
34. 5-Aminosalicylic acid in a slow-release preparation: Bioavailability, plasma level, and excretion in humans
35. Mesalamine in Crohn's disease with steroid-induced remission: Effect on steroid withdrawal and remission maintenance
36. Possible mode of action of 5-aminosalicylic acid
37. Arachidonic acid metabolism and intracellular calcium concentrations in inflammatory bowel disease
38. Mediatoren der Entzuendung und Allergie
39. Medical therapy of active Crohn's disease
40. Long-term experience with 6-mercaptopurine in the treatment of Crohn's disease
41. Long-term follow up of patients with Crohn's disease treated with azathioprine or 6-mercaptopurine